Treatment strategies for the cognitive deficits of Alzheimer's disease.
Meador
K J
KJ
Department of Neurology and Pharmacology/Toxicology, Medical College of Georgia, Augusta 30912-3280.
D000544:Alzheimer Disease / Q000150:complications* / Q000378:metabolism; D000682:Amyloid / Q000378:metabolism; D000928:Antidepressive Agents / Q000627:therapeutic use; D018679:Cholinergic Agonists / Q000627:therapeutic use; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006801:Humans; D018697:Nootropic Agents / Q000627:therapeutic use; D012106:Research; D013565:Sympatholytics / Q000627:therapeutic use; D013831:Thiamine / Q000627:therapeutic use
D000682:Amyloid; D000928:Antidepressive Agents; D018679:Cholinergic Agonists; D018697:Nootropic Agents; D013565:Sympatholytics; D013831:Thiamine